Friday, March 5, 2021
Home Life Style Health & Fitness Researchers Discover Small Molecule Effective in Treating Kidney Cancer

Researchers Discover Small Molecule Effective in Treating Kidney Cancer

The findings, to be published in the journal The Lancet, found that patients receiving sunitinib went a median of 5.6 months before their cancer progressed

Researchers have found that the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer among three targeted drugs.

The findings, to be published in the journal The Lancet, found that patients receiving sunitinib went a median of 5.6 months before their cancer progressed; patients receiving savolitinib and crizotinib fared much worse overall. But cabozantinib, which inhibits VEGF receptors and AXL in addition to MET, gave patients a median of 9.2 months before their cancer progressed, the study indicated.

Please Follow NewsGram on Facebook To Get Latest Updates!

“The magnitude of the response was surprising,” said researcher Sumanta Pal from the City of Hope in the US said. “We still have a long way to go to help make patients’ lives longer and better, but we do have a new standard treatment for these rare cancer patients,” Pal added.

Cancer
Researchers have found that the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer among three targeted drugs. Unsplash

Mutations in the MET gene are a hallmark of this type of cancer, and there are new drugs that target the MET gene among other important signalling pathways, the researcher said. For the study, the team studied 147 eligible patients with papillary kidney cancer, most of whom had not received any prior treatment.

ALSO READ: Thrilling Account Of Love During World War II

Patients were randomly assigned to one of four treatment groups – those who took sunitinib and those who took one of the three MET target drugs — cabozantinib, crizotinib, and savolitinib. The team wanted to see how long it would take patients’ cancer to spread or return, a measure known as progression-free survival. In addition to the result, the team also found, 23 per cent of patients had a significant reduction in the size of their tumour with cabozantinib. In contrast, only 4 per cent of patients saw this kind of tumour response with sunitinib. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

New App That May Help in Quitting Drug Use!

Researchers at the University of Illinois Urbana-Champaign are developing a new smartphone app that may help teach young adults how to talk to a...

Good News! These Regional Biggies Are All Set To Go Multillingual!

Top superstars of regional cinema have a new formula to reach out to a pan-Indian audience. While earlier, films would be made in one...

WhatsApp Launched One-to-One Call Feature For Desktop Apps

WhatsApp on Thursday announced that private and secure one-to-one voice and video calls features are now available on the desktop app for Windows and...

IIT G Designed An AI Based System To Detect Colorectal Cancer

A team of researchers from the Indian Institute of Technology (IIT) Guwahati has designed an automated Artificial Intelligence (AI)-based system to detect colorectal cancer...

Issue of Drug Abuse and Crime Against Women Are Interlinked: Ravi Kishan

Actor-politician Ravi Kishan will soon anchor the crime-based non-fiction show Mauka-E-Vardaat, and he says the issues of drug abuse and a crime against women...

SC Expresses Displeasure on The Streaming of Films on OTT With Pornographic Content

The Supreme Court on Thursday expressed displeasure on the streaming of films on web platforms without any prior screening of the content and also...

Forearm Fracture – Here’s What You Need To Know

It won't be wrong to say that traumatic injuries are unexpected. You never know when an accident would occur or even a slight fall...

Indian Scientists Develop Low-Cost Optical Spectrograph That Can Locate Distant Galaxies, Quasars

Keeping in mind Prime Minister's call to develop technology in all spheres, Indian scientists have indigenously designed and developed a low-cost optical spectrograph. This...

Recent Comments